4A5 Stock Chart & Stats
€20.45
€0.60(3.68%)
At close: 4:00 PM EST
€20.45
€0.60(3.68%)
Day’s Range― - ―
52-Week Range€19.40 - €25.15
Previous CloseN/A
Volume0.00
Average Volume (3M)64.00
Market Cap
€1.71B
Enterprise Value€1.85K
Total Cash (Recent Filing)€115.92M
Total Debt (Recent Filing)€386.73M
Price to Earnings (P/E)18.8
Beta0.29
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.10
Shares Outstanding73,773,100
10 Day Avg. Volume80
30 Day Avg. Volume64
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Fagron SA News
4A5 FAQ
What was Fagron SA’s price range in the past 12 months?
Fagron SA lowest stock price was €19.40 and its highest was €25.15 in the past 12 months.
What is Fagron SA’s market cap?
Fagron SA’s market cap is €1.71B.
When is Fagron SA’s upcoming earnings report date?
Fagron SA’s upcoming earnings report date is Jul 30, 2026 which is in 3 days.
How were Fagron SA’s earnings last quarter?
Fagron SA released its earnings results on Feb 12, 2026. The company reported €0.621 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Fagron SA overvalued?
According to Wall Street analysts Fagron SA’s price is currently Overvalued.
Does Fagron SA pay dividends?
Fagron SA does not currently pay dividends.
What is Fagron SA’s EPS estimate?
Fagron SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fagron SA have?
Fagron SA has 73,773,100 shares outstanding.
What happened to Fagron SA’s price movement after its last earnings report?
Fagron SA reported an EPS of €0.621 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.847%.
Which hedge fund is a major shareholder of Fagron SA?
Currently, no hedge funds are holding shares in DE:4A5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fagron SA
Fagron N.V. operates as a pharmaceutical compounding enterprise, dedicated to providing customized medicinal solutions for hospitals, pharmacies, clinics, and individual patients. The company is actively involved in developing innovative concepts, delivery systems, and formulations within the compounding sector. Its extensive offerings encompass essential raw materials, specialized equipment, semi-finished products, various drug vehicles, and both sterile and non-sterile custom-prepared medications. Additionally, through the Fagron Academy, the firm delivers educational and training programs to healthcare prescribers and pharmacists. With a significant global footprint, Fagron conducts operations across Latin America, North America, Europe, the Middle East, and Africa. Founded in 1990 and headquartered in Nazareth, Belgium, the company adopted its current name, Fagron NV, in January 2015, having previously been known as Arseus NV.